Manufacturing / Biological Products, Except Diagnostic Substances
NEUROCRINE BIOSCIENCES INC
NBIX
$165.14
+$20.25 (+13.93%)
Price as of Nov 3, 2026 15:24 UTC
16 B
Market Cap (Large Cap)
55%
IV Rank
37.1%
Implied Volatility
Nov 03
Next Earnings
Technical Signals
as of Oct 30
Mixed
3 of 7
Trend
- Above 20-day average $143.33
- Above 50-day average $146.80
- Above 200-day average $146.81 · -0.5%
- Moving averages stacked Not aligned
Momentum
- Golden cross (50/200) Down · today
- Momentum cross (20/50) Down · 53d ago
Volume
- Below-average volume 1.1x avg
Price & Trend
Daily candles with EMA 20, SMA 50. Drag to zoom.
Options Activity & Greeks
Implied volatility, flow, and dealer positioning from the options market.
Put/Call Ratio
0.23
Bullish skew
Implied Volatility
37.1%
1% percentile
IV vs Realized
Options cheap
30d HV 41.9%
Options Heat Map
Delta-risk grid for NBIX options across strikes and expirations. Hover any cell for full Greeks.
Loading option chain data...
Insider Trades
0 buys
43 sells
| Date | Insider | Title | Type | Shares | Value | Since Trade |
|---|---|---|---|---|---|---|
| Sep 14, 2026 | ABERNETHY MATT | Sell | 2,311 | $363,285 | -7.5% | |
| Sep 14, 2026 | Boyer David W. | Sell | 826 | $130,051 | -7.7% | |
| Sep 11, 2026 | GORMAN KEVIN CHARLES | Tax_withholding | 7,839 | $1,224,609 | -7.0% | |
| Sep 11, 2026 | Keswani Sanjay Chandru | Tax_withholding | 2,112 | $329,937 | -7.0% | |
| Sep 11, 2026 | GORMAN KEVIN CHARLES | Grant | 14,343 | $0 | -7.0% | |
| Sep 11, 2026 | Keswani Sanjay Chandru | Grant | 3,914 | $0 | -7.0% | |
| Sep 11, 2026 | Delaet Ingrid | Grant | 4,483 | $0 | -7.0% | |
| Sep 11, 2026 | Delaet Ingrid | Tax_withholding | 2,419 | $377,896 | -7.0% | |
| Sep 11, 2026 | Boyer David W. | Tax_withholding | 1,936 | $302,442 | -7.0% | |
| Sep 11, 2026 | Boyer David W. | Grant | 3,587 | $0 | -7.0% |
Politician Trades in NBIX
| Date | Politician | Party | Type | Amount | Since Buy |
|---|---|---|---|---|---|
| Jun 17, 2025 | Lisa C. McClain | R | Sale | $1K-$15K | — |
| Jun 17, 2025 | Lisa C. McClain | R | Sale | $1K-$15K | — |
| Jun 11, 2025 | Lisa C. McClain | R | Purchase | $1K-$15K | +17.7% |
| Nov 19, 2024 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Nov 19, 2024 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Aug 26, 2024 | Michael T. McCaul | R | Sale | $1K-$15K | — |
| Aug 26, 2024 | Michael T. McCaul | R | Sale | $1K-$15K | — |
| Oct 27, 2023 | Michael T. McCaul | R | Sale | $50K-$100K | — |
| Oct 27, 2023 | Michael T. McCaul | R | Sale | $15K-$50K | — |
| Aug 14, 2023 | Michael T. McCaul | R | Purchase | $50K-$100K | +38.4% |
Earnings History
| Date | Quarter | EPS Est. | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Nov 02, 2026 | Q3 2026 | $1.95 | |||
| Oct 26, 2026 | Q3 2026 | $1.96 | |||
| Sep 30, 2026 | Q3 2026 | $1.95 | $3.29 | +68.9% | Beat |
| Aug 04, 2026 | Q2 2026 | $1.59 | |||
| Jul 30, 2026 | Q2 2026 | $1.36 | |||
| Jul 28, 2026 | Q2 2026 | $1.61 | |||
| Jun 30, 2026 | Q2 2026 | $1.37 | $1.39 | +1.5% | Beat |
| Mar 31, 2026 | Q1 2026 | $1.20 | $1.91 | +59.5% | Beat |
Track NBIX with ThetaPal
Get insider trade alerts, AI portfolio analysis, and options roll recommendations for NBIX and your entire portfolio.